Omega Fund Management, LLC
Boston MA · SEC CIK 0001637359
$1.63亿2026Q1 申报市值
10持仓数
100.0%前十大占比 · 第一大 29.2%
0 / 1新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q1 买入最多 按季末市值估算
BCAX 加仓+$372.94万
2026Q1 卖出最多 按季末市值估算
UPB 清仓-$3,600.89万
ALMS 减仓-$907.57万
KMTS 减仓-$700.42万
2026Q1 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | $4,757.99万 | 29.16% | 2,392,150 | 187,500 | 8.5% | $372.94万 | 加仓 |
| NUVB | Nuvation Bio Inc. | $3,466.79万 | 21.25% | 8,081,089 | 0 | 0.0% | — | 不变 |
| BBOT | BridgeBio Oncology Therapeutics Inc. | $2,944.25万 | 18.05% | 3,289,661 | 0 | 0.0% | — | 不变 |
| KMTS | Kestra Med Technologies Ltd | $2,037.14万 | 12.49% | 1,022,149 | -351,442 | -25.6% | -$700.42万 | 减仓 |
| BBNX | Beta Bionics Inc. | $1,318.82万 | 8.08% | 1,316,183 | 0 | 0.0% | — | 不变 |
| — | enGene Holdings Inc. | $596.80万 | 3.66% | 876,357 | 0 | 0.0% | — | 不变 |
| ALMS | Alumis Inc. | $531.48万 | 3.26% | 241,255 | -411,968 | -63.1% | -$907.57万 | 减仓 |
| SANA | Sana Biotechnology, Inc. | $243.00万 | 1.49% | 843,750 | 0 | 0.0% | — | 不变 |
| — | ImageneBio, Inc. | $227.68万 | 1.40% | 455,361 | 0 | 0.0% | — | 不变 |
| REPL | Replimune Group | $190.98万 | 1.17% | 248,672 | 0 | 0.0% | — | 不变 |
| UPB | Upstream Bio Inc. | $0 | 0.00% | 0 | -1,326,293 | -100.0% | -$3,600.89万 | 清仓 |